Highlights of agreement ASCEND’s IT software is used by 50,000 hospitals, clinics, and caregivers. Initial two-year term for North American markets. Ventripoint will be integrated into ASCEND’s IT for cardiovascular care. Toronto, Ontario – December 12, 2023 – Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company“), (TSXV: VPT; OTC: VPTDF), now bringing its AI-powered heart-scanning technology to the world’s hospitals, is pleased to announce it has entered into a global

Toronto, Ontario – The Newswire – August 18, 2023 – Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company“), (TSXV:VPT; OTC:VPTDF) is thrilled to announce that Ventripoint and ASCEND Cardiovascular, LLC have developed a new integrated product. Today’s announcement marks a significant milestone in Ventripoint’s commitment to the collaboration between the two companies. ASCEND fits perfectly into Ventripoint’s roadmap for innovation and is a key step in the company’s miss

Toronto, Ontario – The Newswire – August 10, 2023 – Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company“), (TSXV:VPT; OTC:VPTDF) is thrilled to announce that Ventripoint and Ascend Cardiovascular, a leading provider of cardiovascular IT solutions, have solidified a strategic collaboration. The two companies have signed a letter of intent to explore joint research and development initiatives, knowledge sharing, and combining efforts to bring innovative AI-based solutio

ASCEND Cardiovascular, a leader in cardiovascular structured reporting and workflow innovation, announces the issuance of a patent by the United States Patent and Trademark Office (USPTO), covering its AI-based solution for Categorical Hanging Image Protocols (CHIP). Using AI-based image analysis and machine learning, CHIP automatically categorizes adult Transthoracic Echo (TTE) images by view/modality. This allows ASCEND’s InView solution to intelligently organize and displa